1. Home
  2. XRAY vs XNCR Comparison

XRAY vs XNCR Comparison

Compare XRAY & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

HOLD

Current Price

$9.46

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$25.06

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRAY
XNCR
Founded
1899
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
XRAY
XNCR
Price
$9.46
$25.06
Analyst Decision
Hold
Buy
Analyst Count
17
14
Target Price
$12.67
★ $31.42
AVG Volume (30 Days)
★ 4.5M
1.2M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
★ 1.68%
N/A
EPS Growth
33.04
★ 65.36
EPS
★ 0.14
N/A
Revenue
N/A
★ $125,576,000.00
Revenue This Year
N/A
$14.05
Revenue Next Year
$1.28
N/A
P/E Ratio
$68.11
★ N/A
Revenue Growth
N/A
★ 13.65
52 Week Low
$8.32
$10.38
52 Week High
$14.76
$30.61

Technical Indicators

Market Signals
Indicator
XRAY
XNCR
Relative Strength Index (RSI) 53.98 52.87
Support Level $9.41 $23.07
Resistance Level $10.66 $26.18
Average True Range (ATR) 0.33 1.40
MACD 0.18 0.13
Stochastic Oscillator 90.24 73.25

Price Performance

Historical Comparison
XRAY
XNCR

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: